Raising accessibility to Amplidiag® gastrointestinal diagnostics tests in Europe
ESPOO, Finland, June 23, 2016 – Mobidiag Ltd, a Finnish molecular diagnostics company, today announced an agreement with Isogen Life Science, provider of instruments, reagents and consumables for the life sciences market, for the distribution of the Amplidiag® product line. Under this new agreement Isogen becomes the exclusive distributor of Amplidiag®, in vitro diagnostics for gastrointestinal infections, in Belgium, the Netherlands, Luxembourg and Spain.
“Since Mobidiag’s inception, we have been focusing our activity towards Nordic region and France mainly. We are now in a phase of great expansion and extending our European coverage with the support of reliable partners. In that perspective, we are very pleased to announce our agreement with Isogen Life Science to distribute our Amplidiag® products in high potential markets such as Benelux and Spain” said Tuomas Tenkanen, CEO at Mobidiag.
“Since the molecular diagnostic market has developed as a reliable diagnostic tool, Isogen Life Science has focused on the more niche sample streams within this market. The agreement with Mobidiag enables us to offer our customers a complete solution for the widest spectrum of infections found in such a niche being stool sample. Enabling controlled reliable results from sample to result.” said Martin Donker, CEO at Isogen Life Science.
The distribution agreement with Isogen Life Science is effective immediately and covers all Amplidiag® products (Amplidiag® H. pylori+ClariR, Amplidiag® Stool Parasites, Amplidiag® CarbaR+VRE, Amplidiag® C. difficile+027, Amplidiag® Bacterial GE, Amplidiag® Easy and upcoming Amplidiag® Viral GE).
About Mobidiag
Established in 2000, Mobidiag has developed novel technologies for improving the diagnostics of infectious diseases and has served the European clinical diagnostics market since 2008. Mobidiag is headquartered in Espoo, Finland, with a subsidiary in Paris, France.
Mobidiag’s Amplidiag® product line encompasses innovative molecular diagnostic tests for gastrointestinal infections. The products utilize well-established real-time PCR technology, ensuring optimal performance, suitability for high-volume screening use and cost-effectiveness in mid-sized to large laboratory settings.
About Isogen
Isogen Life Science provides a wide range of instruments, reagents and consumables in the areas of cell biology, molecular biology and biochemistry. These products are used by biotechnology companies and leading research institutes. Isogen is headquartered in De Meern (the Netherlands) with sales offices in Barcelona (Spain).
For more information
Mobidiag Oy/Ltd. CEO
Tuomas Tenkanen
+350 50 553 4980
